Vaccines Market: Meticulous Research Reveals Why This Market Is Growing At A Cagr Of 7.9% To Reach U

By Author: Saavi Bangar
Total Articles: 9
Comment this article

Vaccines represent one of the greatest achievements of science and medicine in the fight against infectious diseases. Vaccination is one of the most cost-effective public health tools to prevent infectious diseases. Significant progress has been made in expanding the coverage of vaccines globally, resulting in the prevention of more than two million deaths annually. Meticulous Research(R) in its latest publication on vaccines market states that the global vaccines market will increase at a CAGR of 7.9% from 2018 to 2025 to reach USD 57,501.8 million by 2025.

The growth of the global vaccines market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines. Furthermore, the increasing epidemic potentials and growing focus on therapeutic vaccines are expected to offer significant growth opportunities for players operating in the vaccines market.

To provide efficient analysis, Meticulous Research has segmented this market on the basis of indication (pneumococcal, ...
... influenza, DTP, HPV, hepatitis, meningococcal, rotavirus, polio, MMR), type (live, toxoid), route of administration (IM, SC, oral), valence (monovalent, multivalent), and geography.

Wherein, geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to its well established vaccination programs, increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players.

While in terms of indication, pneumococcal disease accounted for the largest share in the global vaccines market in 2017. The large share of this segment is mainly attributed to high prevalence of pneumococcal disease in pediatric, elderly, and immune compromised populations. In addition, growing number of pneumococcal diseases resulting in chronic illnesses is further driving the adoption of the pneumococcal vaccines globally.

The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including GSK, Merck & Co., Inc., Pfizer, and Sanofi, CSL Limited, Emergent BioSolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda, and AstraZeneca.

Vaccines Market by Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography - Global Forecast To 2025

Browse detailed TOC @ https://www.meticulousresearch.com/product/vaccines-market/

Key Topics Covered in This Report:

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
3.1. Introduction
3.2. Market Dynamics
3.3. Product Segment Analysis
3.4. Regional Market Analysis
3.5. Competitive Analysis
4. Market Insights
4.1. Market Overview
4.2. Market Dynamics
4.3. Drivers
4.3.1. Strong Vaccines Pipeline
4.3.2. Rising Adoption of Vaccination
4.3.3. Increasing Government Focus on Immunization Programs
4.3.4. Technological Progress in Vaccine Administration
4.4. Restraints
4.4.1. High Cost Associated with Vaccine Development
4.4.2. Longer Timelines for Vaccine Manufacturing
4.5. Opportunities
4.5.1. Increasing Epidemic Potentials
4.5.2. Growing Focus on Therapeutic Vaccines
4.5.3. Growth Prospects in Emerging Markets
4.5.4. Increasing Use of Adjuvants in Vaccines
4.6. Challenges
4.6.1. Product Recalls
4.6.2. Inadequate Access to Vaccines
5. Industry Analysis
5.1. Regulatory Analysis
5.2. Pipeline Analysis
5.3. Unmet Needs Analysis
5.4. Pricing Analysis, by Region
6. Global Vaccines Market, by Indication
6.1. Overview
6.2. Pneumococcal Disease
6.3. Influenza
6.4. DTP
6.5. Human Papilloma Virus (HPV)
6.6. Meningococcal Disease
6.7. Poliomyelitis (Polio)
6.8. MMR
6.9. Rotavirus
6.10. Hepatitis
6.11. Others
7. Global Vaccines Market, by Route of Administration
7.1. Overview
7.2. Intramuscular (IM)
7.3. Subcutaneous (SC)
7.4. Oral
7.5. Other (Routes of Administration)
8. Global Vaccines Market, by Type/Antigen
8.1. Overview
8.2. Subunit & Conjugate Vaccines
8.3. Inactivated Vaccines
8.4. Live Attenuated Vaccines
8.5. Toxoid Vaccines
9. Global Vaccines Market, by Valence
9.1. Overview
9.2. Multivalent Vaccines
9.3. Monovalent Vaccines
10. Vaccines Market, by Region
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. U.K.
10.3.2. Germany
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia Pacific
10.5. Latin America
10.6. Middle East & Africa
11. Competitive Landscape
11.1. Overview
11.2. Competition Matrix
11.3. Market Share Analysis
11.3.1. Market Share Analysis, by Company
11.3.2. Market Share Analysis, by Product
12. Company Profiles
12.1. Sanofi Pasteur
12.2. Merck & Co., Inc.
12.3. GlaxoSmithKline Plc
12.4. Pfizer, Inc.
12.5. Johnson & Johnson
12.6. Daiichi Sankyo
12.7. Takeda Pharmaceutical Co. Ltd.
12.8. CSL Limited
12.9. Emergent BioSolutions Inc.
12.10. AstraZeneca
13. Appendix
13.1. Questionnaire
Get Free sample report here: https://www.meticulousresearch.com/request-sample-report/?cp_id=4813